Immix Biopharma (IMMX) Property, Plant & Equipment (Net) (2020 - 2026)

Immix Biopharma (IMMX) Property, Plant & Equipment (Net) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 66,200.25 Bn 66,199.96 Bn - 642,333.36
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn - 5.32 Mn
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 471.75 Bn 466.96 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 121.94 Bn 114.69 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 69.87 Bn 61.12 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.43 Bn 62.43 Bn - -
8 Argenx Se 55.86 Bn 50.68 Bn 1.41 Bn 1.96 Bn
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn 518.26 Mn
10 Immix Biopharma 486.69 Mn 486.69 Mn - 2.43 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.43 Mn
Mar 31, 2026 2.43 Mn
Dec 31, 2025 2.52 Mn
Dec 31, 2025 2.52 Mn
Sep 30, 2025 2.36 Mn
Sep 30, 2025 2.36 Mn
Jun 30, 2025 1.04 Mn
Jun 30, 2025 1.04 Mn
Mar 31, 2025 946,685.00
Mar 31, 2025 946,685.00
Dec 31, 2024 1.74 Mn
Dec 31, 2024 1.74 Mn
Sep 30, 2024 844,019.00
Sep 30, 2024 844,019.00
Jun 30, 2024 358,607.00
Jun 30, 2024 358,607.00
Mar 31, 2024 360,834.00
Mar 31, 2024 360,834.00
Dec 31, 2023 50,181.00
Dec 31, 2023 50,181.00